(Q35111592)

6 August 2017

1 reference

title

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression (English)

1 reference

6 August 2017

Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for Difficult-to-Treat depression (English)

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00117-3

26 December 2023

1 reference

Jonathan Sporn

3

1 reference

6 August 2017

Kirk Denicoff

5

1 reference

6 August 2017

Neil A Gray

6

1 reference

6 August 2017

Husseini K. Manji

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

26 December 2023

Jorge A. Quiroz

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

26 December 2023

Jennifer L. Payne

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

26 December 2023

Carlos A. Zarate

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

26 December 2023

Dennis S. Charney

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

26 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

6 August 2017

15 April 2003

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706957

full work available at URL

26 December 2023

https://zenodo.org/record/1259549/files/article.pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706957

https://api.elsevier.com/content/article/PII:S0006322303001173?httpAccept=text/xml

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00117-3

https://api.elsevier.com/content/article/PII:S0006322303001173?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00117-3

26 December 2023

published in

Biological Psychiatry

1 reference

6 August 2017

volume

53

1 reference

6 August 2017

issue

8

1 reference

6 August 2017

page(s)

707-742

1 reference

The Bcl-2 protein family: arbiters of cell survival

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Plasma and platelet excitatory amino acids in psychiatric disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The hippocampus and parahippocampus in schizophrenia, suicide, and control brains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Alterations of cAMP response element-binding activity in the aged rat brain in response to administration of rolipram, a cAMP-specific phosphodiesterase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Survival signaling and selective neuroprotection through glutamatergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduced volume of limbic system-affiliated basal ganglia in mood disorders: preliminary data from a postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Rapid reversal of psychotic depression using mifepristone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

An open label trial of C-1073 (mifepristone) for psychotic major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A reduction of nonpyramidal cells in sector CA2 of schizophrenics and manic depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Platelet glutamate receptor supersensitivity in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressant effects of ketamine in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Volumetric brain imaging findings in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Is phosphodiesterase inhibition a new mechanism of antidepressant action? A double blind double-dummy study between rolipram and desipramine in hospitalized major and/or endogenous depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Anterior cingulate cortex pathology in schizophrenia and bipolar disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Acute application of the tricyclic antidepressant desipramine presynaptically stimulates the exocytosis of glutamate in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Low glial numbers in the amygdala in major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Chronic administration of imipramine and citalopram alters the expression of NMDA receptor subunit mRNAs in mouse brain. A quantitative in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Long-term, progressive hippocampal cell loss and dysfunction induced by early-life administration of corticotropin-releasing hormone reproduce the effects of early-life stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Restoring production of hippocampal neurons in old age.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A bivariate genetic analysis of cerebral white matter hyperintensities and cognitive performance in elderly male twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The neuropsychiatry of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Expression of the cAMP response element binding protein (CREB) in hippocampus produces an antidepressant effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Bcl-2 promotes regeneration of severed axons in mammalian CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Why do mature CNS neurons of mammals fail to re-establish connections following injury--functions of bcl-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Enhancement of hippocampal neurogenesis by lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Optic nerve crush: axonal responses in wild-type and bcl-2 transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduced glial cell density and neuronal size in the anterior cingulate cortex in major depressive disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Mind glue: implications of glial cell biology for psychiatry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cyloserine as an antidepressant agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Tryptophan-depletion challenge in depressed patients treated with desipramine or fluoxetine: implications for the role of serotonin in the mechanism of antidepressant action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Social stress exacerbates stroke outcome by suppressing Bcl-2 expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Magnetic resonance assessment of cerebral perfusion in depressed cardiac patients: preliminary findings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroimaging studies of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressants and neuroplasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neural plasticity to stress and antidepressant treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Update on the therapeutic potential of PDE4 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neurogenesis in the adult human hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

CREB couples neurotrophin signals to survival messages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Nongenomic transmission across generations of maternal behavior and stress responses in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Developmental and mature expression of full-length and truncated TrkB receptors in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Administration of a cAMP phosphodiesterase 4 inhibitor enhances antidepressant-induction of BDNF mRNA in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Genetic disruption of mineralocorticoid receptor leads to impaired neurogenesis and granule cell degeneration in the hippocampus of adult mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Psychological stress increases hippocampal mineralocorticoid receptor levels: involvement of corticotropin-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A placebo-controlled pilot study of the ampakine CX516 added to clozapine in schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Modulation of neurotransmitter release induced by brain-derived neurotrophic factor in rat brain striatal slices in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

New insights into the role of cortisol and the glucocorticoid receptor in severe depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Dendritic spine density of adult hippocampal pyramidal cells is sensitive to thyroid hormone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Regulation of hippocampal neurogenesis in adulthood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The hippocampal formation: morphological changes induced by thyroid, gonadal and adrenal hormones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Signaling networks in the pathophysiology and treatment of mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Oral administration of a corticotropin-releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Borderline hypothyroidism and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Facilitative effects of the ampakine CX516 on short-term memory in rats: enhancement of delayed-nonmatch-to-sample performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The AMPA receptor interacts with and signals through the protein tyrosine kinase Lyn

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

GLIA: listening and talking to the synapse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium carbonate augmentation of antidepressant treatment. An effective prescription for treatment-refractory depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The role of N-methyl-D-aspartate (NMDA) receptor-mediated neurotransmission in the pathophysiology and therapeutics of psychiatric syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

NMDA glutamatergic receptors, labelled with [3H]MK-801, in brain samples from drug-free depressed suicides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Enhanced axonal growth from fetal human bcl-2 transgenic mouse dopamine neurons transplanted to the adult rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The corticosteroid receptor hypothesis of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Support of retinal ganglion cell survival and axon regeneration by lithium through a Bcl-2-dependent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The next generation of PDE4 inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Enhancement by an ampakine of memory encoding in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Adult brain neurogenesis and psychiatry: a novel theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Anti-bipolar therapy: mechanism of action of lithium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Decreased neurotransmitter receptor binding in striatum and cortex from adult hypothyroid rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Subtype-specific effects of lithium on glutamate receptor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Regulation of adult hippocampal neurogenesis - implications for novel theories of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

More hippocampal neurons in adult mice living in an enriched environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A molecular mechanism for the effect of lithium on development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antisense to the glucocorticoid receptor in hippocampal dentate gyrus reduces immobility in forced swim test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Positive modulation of AMPA receptors increases neurotrophin expression by hippocampal and cortical neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Regulation of BDNF expression in primary neuron culture by LY392098, a novel AMPA receptor potentiator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Endophenotypes in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Increased cerebrospinal fluid glutamine levels in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Glycogen synthase kinase-3beta, mood stabilizers, and neuroprotection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressant-like actions of an AMPA receptor potentiator (LY392098).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The developing caudate nucleus in the euthyroid and hypothyroid rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

An electron microscopic study of the developing caudate nucleus in euthyroid and hypothyroid states

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Evidence that a positive modulator of AMPA-type glutamate receptors improves delayed recall in aged humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Early life stress and inherited variation in monkey hippocampal volumes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: modulation by treatment with antidepressants and prediction of clinical responsivity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain-derived neurotrophic factor promotes the survival and sprouting of serotonergic axons in rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressants alter cell proliferation in the adult brain in vivo and in neural cultures in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The cellular neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Signaling: cellular insights into the pathophysiology of bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroplasticity and cellular resilience in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain-derived neurotrophic factor enhances depolarization-evoked glutamate release in cultured cortical neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Stress and hippocampal plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Future therapeutic targets in mood disorders: the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Striatal ionotropic glutamate receptor expression in schizophrenia, bipolar disorder, and major depressive disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Imipramine and phenelzine decrease glutamate overflow in the prefrontal cortex--a possible mechanism of neuroprotection in major depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Morphological brain changes in depression: can antidepressants reverse them?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium-induced increase in human brain grey matter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressants induce regeneration of catecholaminergic axon terminals in the rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neurobiology of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Repeated stress increases catalytic TrkB mRNA in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Adaptation of cortical but not hippocampal NMDA receptors after chronic citalopram treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Alterations in the N-methyl-d-asparatate (NMDA) receptor complex in the frontal cortex of suicide victims

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Swim Stress Increases the Potency of Glycine at the N-Methyl-d-Aspartate Receptor Complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Overexpression of Bcl-2 in a murine dopaminergic neuronal cell line leads to neurite outgrowth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Glial reduction in the subgenual prefrontal cortex in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Abundance of the alpha-subunits of Gi1, Gi2 and Go in synaptosomal membranes from several regions of the rat brain is increased in hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Treatment with triiodothyronine decreases the abundance of the alpha-subunits of Gi1 and Gi2 in the cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Corticotropin-releasing factor antagonists in affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Controlled trial of amantadine hydrochloride in Parkinson's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Trk receptors: mediators of neurotrophin action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Down-regulation of cortical beta-adrenoceptors by chronic treatment with functional NMDA antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Timing is everything: does the robust upregulation of noradrenergically regulated plasticity genes underlie the rapid antidepressant effects of sleep deprivation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Molecular targets of lithium action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A quantitative magnetic resonance imaging study of cerebral and cerebellar gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neurotrophins as synaptic modulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Novel uses of thyroid hormones in patients with affective disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Histopathology of the prefrontal cortex in major depression: what does it tell us about dysfunctional monoaminergic circuits?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cell pathology in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antiglucocorticoid drugs in the treatment of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Tricyclic antidepressants block N-methyl-D-aspartate receptors: similarities to the action of zinc

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Thyroxine treatment and the recovery of pyramidal cells of the cerebral cortex from changes induced by juvenile-onset hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Severe hypothyroidism and the maturation of the rat cerebral cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reversible morphological alterations of cortical neurons in juvenile and adult hypothyroidism in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Distribution of corticosteroid receptors in the rhesus brain: relative absence of glucocorticoid receptors in the hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Stress, Glucocorticoids, and Damage to the Nervous System: The Current State of Confusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Postsynaptic target specificity of neurotrophin-induced presynaptic potentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Serum cortisol response to transsphenoidal surgery for Cushing disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Antidepressants for the new millennium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Current perspectives on the development of non-biogenic amine-based antidepressants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cerebrovascular disease and depression symptoms in the cardiovascular health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Structural neuroimaging and mood disorders: recent findings, implications for classification, and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neuroimaging in bipolar disorder: what have we learned?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Chronic antidepressant administration increases the expression of cAMP-specific phosphodiesterase 4A and 4B isoforms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Increase of bcl-2 protein in neuronal dendritic processes of cerebral cortex and hippocampus by the antiparkinsonian drugs, talipexole and pramipexole

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Evidence of white matter tract disruption in MRI hyperintensities.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Neurotrophins and neuronal plasticity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cell adhesion molecule expression in the dorsolateral prefrontal cortex and anterior cingulate cortex in major depression in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Elevation in Late-Life Depression of Intercellular Adhesion Molecule-1 Expression in the Dorsolateral Prefrontal Cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Functional antagonists at the NMDA receptor complex exhibit antidepressant actions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

N-acetylaspartate in neuropsychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Control of synapse number by glia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Amantadine in depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Tianeptine attenuates stress-induced morphological changes in the hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Dendritic reorganization in pyramidal neurons in medial prefrontal cortex after chronic corticosterone administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Results of a phase II study of the antidepressant effect of rolipram

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduction of temporal lobe volume in bipolar disorder: a preliminary report of magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Ventricular abnormalities in affective disorder: clinical and demographic correlates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal/amygdala volumes in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain MRI lesions and atrophy are related to depression in multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Changes in CSF spaces differ in endogenous and neurotic depression. A planimetric CT scan study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Ventricular enlargement and caudate hyperdensity in elderly depressives

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Volumetric reduction in left subgenual prefrontal cortex in early onset depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Differential effects of age on brain gray matter in bipolar patients and healthy individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

MRI study of posterior fossa structures and brain ventricles in bipolar patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduced volume of orbitofrontal cortex in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal volume reduction in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cognitive impairment and cerebral structure by MRI in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Structural and functional abnormalities in elderly patients clinically recovered from early- and late-onset depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A magnetic resonance imaging study of thalamic area in adolescent patients with either schizophrenia or bipolar disorder as compared to healthy controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

MRI analysis of the cerebellum in bipolar disorder: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Bipolar affective disorder. I. Comprehensive quantitative computed tomography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The cerebral cortical appearance in depressed subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Subgenual prefrontal cortex abnormalities in mood disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

An MRI study of adolescent patients with either schizophrenia or bipolar disorder as compared to healthy control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Enlargement of the amygdala in patients with a first episode of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal changes in patients with a first episode of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Temporal lobe measurement in primary affective disorder by magnetic resonance imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

MRI-based measurements of temporal lobe and ventricular structures in patients with bipolar I and bipolar II disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A magnetic resonance imaging study of putamen nuclei in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hypothyroidism as a correlate of lateral ventricular enlargement in manic-depressive and neurotic illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Atrophy and high intensity lesions: complementary neurobiological mechanisms in late-life major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Late-onset minor and major depression: early evidence for common neuroanatomical substrates detected by using MRI

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Quantitative anatomic measures and comorbid medical illness in late-life major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Reduction of orbital frontal cortex volume in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cortical gray matter deficit in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Quantitative MRI of the hippocampus and amygdala in severe depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A volumetric magnetic resonance imaging study of monozygotic twins discordant for bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Magnetic-resonance morphometry in patients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Clinical correlates of lateral ventricular enlargement in bipolar affective disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Computerised tomographic scan changes in manic-depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

A quantitative magnetic resonance imaging study of caudate and lenticular nucleus gray matter volume in primary unipolar major depression: relationship to treatment response and clinical severity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

MRI findings differentiate between late-onset schizophrenia and late-life mood disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cortical magnetic resonance imaging changes in elderly inpatients with major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Temporal horn enlargement is present in schizophrenia and bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Decreased pituitary volume in patients with bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Frontosubcortical neuroanatomy and the continuous performance test in mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Computed tomography in affective disorders. Part II. Brain density

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Posterior fossa abnormalities in major depression: a controlled magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Amygdala core nuclei volumes are decreased in recurrent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal atrophy in recurrent major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Depression and ventricular enlargement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

The differentiation of DSM-III-R psychotic depression in later life from nonpsychotic depression: comparisons of brain changes measured by multispectral analysis of magnetic resonance brain images, neuropsychological findings, and clinical features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Regional cerebral volume measurements in late-life depression: relationship to clinical correlates, neuropsychological impairment and response to treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal volume in geriatric depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Volumetric MRI studies of mood disorders: do they distinguish unipolar and bipolar disorder?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain magnetic resonance imaging of structural abnormalities in bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Structural brain abnormalities in first-episode mania

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Structural brain abnormalities in bipolar affective disorder. Ventricular enlargement and focal signal hyperintensities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Hippocampal volume in first-episode psychoses and chronic schizophrenia: a high-resolution magnetic resonance imaging study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Computed tomography in schizophreniform disorder and other acute psychiatric disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain morphology assessed by computed tomography in patients with geriatric depression, patients with degenerative dementia, and normal control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Brain computed tomography in geriatric manic disorder.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Deficits in gray matter volume are present in schizophrenia but not bipolar disorder

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

Structural brain CT changes and cognitive deficits in elderly depressives with and without reversible dementia ('pseudodementia').

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2803%2900117-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Postreceptor pathways for signal transduction in depression and bipolar disorder

210

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00117-3

Neuroprotective effects of antidepressant and mood stabilizing drugs

26 December 2023

211

1 reference

https://api.crossref.org/works/10.1016/S0006-3223(03)00117-3

26 December 2023

Identifiers

1 reference

6 August 2017

1 reference